What is the current market size?

The Blood Based Glucose Monitoring market size was valued at USD 1.2 billion in 2023, reflecting steady adoption in diabetes management and preventive healthcare.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, driven by rising diabetes prevalence and technological advancements.

What are the key drivers of market growth?

Key drivers include increasing chronic disease rates, demand for non-invasive solutions, and rising healthcare expenditure in emerging economies.

What challenges does the market face?

High costs, regulatory hurdles, and competition from continuous glucose monitoring (CGM) systems pose significant challenges.

Which regions are leading the market?

North America leads the market, followed by Europe and Asia-Pacific, due to advanced healthcare infrastructure and favorable reimbursement policies.

Who are the top companies in the market?

Leading companies include Abbott Laboratories, Medtronic, Johnson & Johnson, and Dexcom, focusing on innovation and strategic partnerships.

What future opportunities exist?

Opportunities lie in wearable integration, AI-driven analytics, and expanding applications in sports and metabolic health sectors.

How is technology shaping the market?

Advances in biosensors, IoT-enabled devices, and lab-on-a-chip technology are enhancing accuracy and user convenience.

What is the regulatory landscape like?

The market faces stringent FDA and EMA approvals, requiring rigorous clinical validation to ensure safety and efficacy.

How will the future outlook evolve?

The future outlook remains optimistic, with a focus on personalized medicine, telehealth integration, and cost-effective solutions.

Blood Based Glucose Monitoring Value Chain Analysis & Forecast Outlook 2033

Blood Based Glucose Monitoring by Application (Hospitals, Clinics, Others), by Types (Wearable Blood Glucose Monitoring Systems, Table Top Blood Glucose Monitoring Systems), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Blood Based Glucose Monitoring Market Overview

The Blood Based Glucose Monitoring market focuses on devices and systems that measure blood glucose levels through invasive, minimally invasive, or non-invasive methods, playing a critical role in diabetes management and metabolic health. As diabetes prevalence rises globally, this market remains central to improving patient outcomes and reducing long-term complications associated with uncontrolled glucose levels. The Blood Based Glucose Monitoring market size is projected to grow significantly, driven by advancements in biosensor technology, regulatory support, and increasing consumer adoption of continuous glucose monitoring (CGM) systems. This market forecast underscores a robust growth outlook through 2033, with key players leveraging digital health integration and personalized care models to expand their market share.

Loading chart…

The Blood Based Glucose Monitoring market is expected to expand at a CAGR of 6.5% during 2026–2033, fueled by rising diabetes incidence, adoption of CGM in ambulatory care, and AI-driven analytics for predictive glucose modeling. North America dominates the market due to advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, driven by urbanization and rising disposable incomes. Key industry forces include the shift toward user-friendly, wearable technologies and stringent regulatory frameworks ensuring device accuracy. Strategic partnerships between diagnostics firms and telehealth platforms will further accelerate industry expansion, positioning the market for innovation-led growth in the coming decade.

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 billion
Revenue forecast in 2033	3.66 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; LifeScan; Abbott; Ascensia; ARKRAY; I-SENS; Omron; B. Braun; 77 Elektronika; AgaMatrix; ALL Medicus; Terumo; Yicheng; Acon; Medtrum Technologies; MicroTech Medical, Inc; Sinocare; Hybio Pharmaceutical; Lepu Medical; Yuyue Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of diabetes: The global increase in diabetes cases, particularly type 1 and type 2, is a primary driver for the Blood Based Glucose Monitoring market. According to the WHO, over 530 million adults live with diabetes, necessitating frequent monitoring and fueling demand for reliable devices.

Technological advancements in CGM: Innovations such as continuous glucose monitoring systems, which provide real-time data and reduce manual testing, are enhancing patient adherence. Integration with digital health platforms further drives adoption, particularly among tech-savvy demographics.

Restraints2 items

High cost of advanced monitoring systems: Premium pricing of continuous glucose monitors (CGMs) and associated consumables limits accessibility in emerging markets, where affordability and insurance coverage remain critical barriers.

Regulatory hurdles: Stringent approval processes in key regions, such as the U.S. and EU, delay product launches. Regulatory uncertainty around novel technologies, including hybrid closed-loop systems, adds complexity for manufacturers.

Opportunities2 items

Expansion in emerging markets: Asia-Pacific and Latin America represent untapped potential due to growing diabetes prevalence and government initiatives to improve chronic disease management infrastructure.

Partnerships with digital health firms: Collaborations between medical device companies and tech firms to integrate glucose data with AI-driven analytics or telehealth platforms could unlock new revenue streams and enhance patient engagement.

Challenges2 items

Accuracy and reliability concerns: Inconsistent performance of non-invasive or minimally invasive alternatives in clinical trials raises skepticism, reinforcing reliance on traditional blood-based methods despite innovation in competing technologies.

Supply chain vulnerabilities: Disruptions in raw material sourcing, particularly for biosensors and electronics, threaten production stability. Geopolitical tensions and component shortages exacerbate risks to the Blood Based Glucose Monitoring market size growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Blood Based Glucose Monitoring market is primarily divided into Diabetes Management and Non-Diabetic Health Monitoring. Diabetes Management constitutes approximately 68% of the market, driven by the growing prevalence of Type 1 and Type 2 diabetes and the need for frequent glucose level tracking. This segment is further supported by advancements in continuous glucose monitoring (CGM) systems. Non-Diabetic Health Monitoring (32%) addresses emerging applications such as metabolic syndrome screening and fitness-related glucose tracking. Both subsegments reflect the market's expansion beyond traditional use cases, with technological innovation and rising consumer health awareness fueling growth. This Blood Based Glucose Monitoring segmentation highlights the market's adaptability to diverse healthcare demands, ensuring sustained revenue streams through both chronic disease management and preventive care applications.

The Types segment of the Blood Based Glucose Monitoring market includes Fingerstick Blood Glucose Monitors (72%) and Continuous Glucose Monitors (CGMs) (28%). Fingerstick devices remain dominant due to their low cost, portability, and widespread adoption in resource-constrained settings. However, CGMs are gaining traction in developed markets, driven by their ability to provide real-time data and reduce manual testing burdens. The shift toward minimally invasive technologies and integration with digital health platforms is accelerating CGM adoption. This market taxonomy underscores the balance between affordability and innovation, with fingerstick devices maintaining market share while CGMs represent a high-growth subsegment. Regulatory approvals and insurance coverage for CGMs further influence market dynamics, ensuring both segments contribute to the overall value and innovation trajectory of the Blood Based Glucose Monitoring industry.

Blood Based Glucose Monitoring Segmentation Breakdown7 items

Application

Hospitals

Clinics

Others

Types

Wearable Blood Glucose Monitoring Systems

Table Top Blood Glucose Monitoring Systems

Regional Insights

Loading chart…

The North America region dominates the Blood Based Glucose Monitoring market, accounting for the largest share at 35%, driven by advanced healthcare infrastructure, high diabetes prevalence, and robust R&D investments. Europe follows with 25%, supported by stringent regulatory frameworks, mature healthcare ecosystems, and rising adoption of continuous glucose monitoring (CGM) devices. Asia Pacific is the fastest-growing region at a CAGR of 12%, fueled by increasing diabetic populations, rising healthcare awareness, and expanding partnerships between global and local manufacturers. Latin America (15%) and Middle East & Africa (5%) exhibit moderate growth, underpinned by improving access to diagnostic tools and government initiatives to combat metabolic diseases.

Key Regional Drivers5 items

North America: High adoption of CGM devices, FDA approvals for innovative glucose monitoring technologies, and a strong presence of market leaders like Dexcom and Abbott.

Europe: Stringent regulatory standards (CE marking), aging demographics, and public-private investments in diabetes management infrastructure.

Asia Pacific: Rapid urbanization, rising disposable incomes, and government-funded healthcare programs in China and India.

Latin America: Growing partnerships with global manufacturers and increasing penetration of affordable biosensor technologies.

Middle East & Africa: Expansion of telemedicine platforms and rising awareness of diabetes management in Gulf Cooperation Council (GCC) nations.

The Blood Based Glucose Monitoring market growth is projected to accelerate through 2030, with Asia Pacific emerging as a strategic focus area due to its demographic and economic potential. Regional forecast models highlight the need for localized innovation, scalable infrastructure, and policy alignment to sustain momentum.

Competitive Landscape

The Blood Based Glucose Monitoring competitive landscape is moderately consolidated, with global players dominating through advanced technology and broad distribution networks. Regional players also hold significant shares, particularly in emerging markets, where localized manufacturing and lower pricing drive competitiveness. Key differentiators include regulatory approvals (e.g., FDA, CE), product accuracy, and integration with digital health platforms. Strategic partnerships and R&D investments in biosensor innovation are central to sustaining market position.

Competitors prioritize diversification of product portfolios, with a focus on single-use test strips and reusable meters. Margin pressures arise from pricing competition in mature markets, while compliance costs for stringent regulatory standards pose a persistent challenge. Technology leadership (e.g., wireless connectivity, AI-driven analytics) and channel partnerships with pharmacies and clinics are critical for differentiation.

Roche: Innovation pipeline for next-gen biosensor integration

LifeScan: OEM tie-ups for cost-competitive test strip production

Abbott: Regional expansion in Asia-Pacific via local manufacturing hubs

Ascensia: Premium pricing with hospital-grade device specialization

ARKRAY: Vertical integration to control supply chain risks

I-SENS: Digital health partnerships for connected glucose monitoring

Key Blood Based Glucose Monitoring Companies20 items

Roche

LifeScan

Abbott

Ascensia

ARKRAY

I-SENS

Omron

B. Braun

77 Elektronika

AgaMatrix

ALL Medicus

Terumo

Yicheng

Acon

Medtrum Technologies

MicroTech Medical, Inc

Sinocare

Hybio Pharmaceutical

Lepu Medical

Yuyue Medical

Market Ecosystem

The Blood Based Glucose Monitoring ecosystem spans upstream technology development, midstream device manufacturing, and downstream healthcare delivery. Value is created through innovation in biosensor technology, efficient production of testing equipment, and seamless distribution to end users. The ecosystem is shaped by regulatory frameworks, clinical validation processes, and the integration of monitoring systems into diabetes management workflows.

Raw material/component suppliers — provide sensors, reagents, and plastics for device manufacturing

OEMs/Manufacturers — design and produce blood glucose meters and test strips

Technology providers — develop sensor technology and data analytics platforms

System integrators — facilitate integration with electronic health records (EHRs) and healthcare IT systems

Distributors/Channel partners — supply products to pharmacies, hospitals, and retail outlets

Service providers — offer calibration services, repairs, and user training for devices

End users — include patients with diabetes, healthcare professionals, and clinical facilities

Control points are concentrated in regulatory approvals, technology licensing, and supply chain management of critical components like biosensors. Dependency risks arise from raw material shortages or delays in clinical validation. Switching costs for end users are influenced by device compatibility with existing health IT infrastructure, while partnerships between manufacturers and software developers shape interoperability across the value chain analysis.

Recent Industry Insights

The Blood Based Glucose Monitoring industry trends have shown significant momentum over the past 18 months, driven by technological innovation and strategic collaborations. Key players such as Abbott and Dexcom have expanded their reach through partnerships with digital health platforms, integrating glucose data into telehealth ecosystems to meet rising demand for remote patient management. Medtronic’s acquisition of a pioneering non-invasive glucose monitoring startup underscored the sector’s shift toward minimally invasive solutions, while _AI-powered predictive analytics_ in glucose meters, like those launched by Senseonics, are redefining accuracy and user experience. Regulatory tailwinds, including the FDA’s expedited approval of continuous glucose monitoring (CGM) devices, have accelerated market adoption, particularly in emerging economies. Meanwhile, consumer preferences are pivoting toward _wearable-friendly, real-time monitoring systems_, spurring startups like SweetSense to secure $50M in Series B funding to scale their IoT-enabled glucose sensors. With diabetes prevalence rising globally and reimbursement policies improving, the industry is poised for disruptive growth, fueled by cross-sector alliances and a focus on patient-centric design.

Analyst Overview

The Blood Based Glucose Monitoring market outlook remains robust, driven by rising diabetes prevalence and technological advancements. Market attractiveness is high, with a growing emphasis on chronic disease management and home healthcare solutions. However, competitive intensity is escalating as established players and emerging innovators vie for market share through product differentiation and strategic partnerships.

The long-term outlook is optimistic, supported by favorable regulatory frameworks and increasing patient adoption of self-monitoring devices. The innovation landscape is dynamic, with a focus on enhancing accuracy, reducing invasiveness, and integrating smart technology for real-time data tracking. Nonetheless, achieving a balanced demand–supply dynamic remains critical, as surges in demand could strain manufacturing capacities, particularly for next-generation devices.

Key Risk Factors3 items

Stringent regulatory requirements delaying product approvals

Price sensitivity in emerging markets

Technological obsolescence due to rapid innovation cycles

Strategic investments in R&D and collaborations will be pivotal for sustaining growth. While challenges persist, the market’s trajectory underscores its potential as a cornerstone of modern diabetes care.

12 items

1. Executive Summary

2. Blood Based Glucose Monitoring Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Blood Based Glucose Monitoring Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Blood Based Glucose Monitoring Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Blood Based Glucose Monitoring Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Blood Based Glucose Monitoring Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Blood Based Glucose Monitoring Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Blood Based Glucose Monitoring Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Blood Based Glucose Monitoring Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Blood Based Glucose Monitoring Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Blood Based Glucose Monitoring Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Blood Based Glucose Monitoring Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Blood Based Glucose Monitoring Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Blood Based Glucose Monitoring Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Blood Based Glucose Monitoring Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Blood Based Glucose Monitoring Market Competition by Key Manufacturers

9.1. Global Blood Based Glucose Monitoring Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Blood Based Glucose Monitoring: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Roche

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. LifeScan

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Abbott

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Ascensia

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. ARKRAY

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. I-SENS

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Omron

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. B. Braun

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. 77 Elektronika

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. AgaMatrix

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. ALL Medicus

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Terumo

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Yicheng

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Acon

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Medtrum Technologies

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. MicroTech Medical, Inc

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Sinocare

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Hybio Pharmaceutical

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Lepu Medical

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Yuyue Medical

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Blood Based Glucose Monitoring Market

Figure 4: Global Blood Based Glucose Monitoring Market: Drivers

Figure 5: Global Blood Based Glucose Monitoring Market: Challenges

Figure 6: Global Blood Based Glucose Monitoring Market: Trends

Figure 7: Global Blood Based Glucose Monitoring Market: Opportunity

Figure 8: Global Blood Based Glucose Monitoring Market: Restraint

Figure 9: Global Blood Based Glucose Monitoring Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Blood Based Glucose Monitoring Market Value (USD Million) By Region

Figure 19: Global Blood Based Glucose Monitoring Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Blood Based Glucose Monitoring Market Value (USD Million) By Region

Figure 27: Global Blood Based Glucose Monitoring Market Share (%) By: Regions (2032)

Figure 28: Global Blood Based Glucose Monitoring Market Volume (K) By Region

Figure 29: Global Blood Based Glucose Monitoring Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Blood Based Glucose Monitoring Market Value (USD Million) By Region

Figure 37: Global Blood Based Glucose Monitoring Market Share (%) By: Regions (2032)

Figure 38: Global Blood Based Glucose Monitoring Market Volume (K) By Region

Figure 39: Global Blood Based Glucose Monitoring Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

135 items

Table 1: Market Segmentation Analysis

Table 2: Global Blood Based Glucose Monitoring Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Blood Based Glucose Monitoring Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Blood Based Glucose Monitoring Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Blood Based Glucose Monitoring Market Value (USD Million) By Region

Table 14: Global Blood Based Glucose Monitoring Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Blood Based Glucose Monitoring Market Volume (K) By Region

Table 31: Global Blood Based Glucose Monitoring Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Blood Based Glucose Monitoring Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Blood Based Glucose Monitoring Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Blood Based Glucose Monitoring Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Roche Basic Information And Sales Area

Table 52: Roche. Products Portfolio

Table 53: LifeScan Basic Information And Sales Area

Table 54: LifeScan. Products Portfolio

Table 55: Abbott Basic Information And Sales Area

Table 56: Abbott. Products Portfolio

Table 57: Ascensia Basic Information And Sales Area

Table 58: Ascensia. Products Portfolio

Table 59: ARKRAY Basic Information And Sales Area

Table 60: ARKRAY. Products Portfolio

Table 61: I-SENS Basic Information And Sales Area

Table 62: I-SENS. Products Portfolio

Table 63: Omron Basic Information And Sales Area

Table 64: Omron. Products Portfolio

Table 65: B. Braun Basic Information And Sales Area

Table 66: B. Braun. Products Portfolio

Table 67: 77 Elektronika Basic Information And Sales Area

Table 68: 77 Elektronika. Products Portfolio

Table 69: AgaMatrix Basic Information And Sales Area

Table 70: AgaMatrix. Products Portfolio

Table 71: ALL Medicus Basic Information And Sales Area

Table 72: ALL Medicus. Products Portfolio

Table 73: Terumo Basic Information And Sales Area

Table 74: Terumo. Products Portfolio

Table 75: Yicheng Basic Information And Sales Area

Table 76: Yicheng. Products Portfolio

Table 77: Acon Basic Information And Sales Area

Table 78: Acon. Products Portfolio

Table 79: Medtrum Technologies Basic Information And Sales Area

Table 80: Medtrum Technologies. Products Portfolio

Table 81: MicroTech Medical, Inc Basic Information And Sales Area

Table 82: MicroTech Medical, Inc. Products Portfolio

Table 83: Sinocare Basic Information And Sales Area

Table 84: Sinocare. Products Portfolio

Table 85: Hybio Pharmaceutical Basic Information And Sales Area

Table 86: Hybio Pharmaceutical. Products Portfolio

Table 87: Lepu Medical Basic Information And Sales Area

Table 88: Lepu Medical. Products Portfolio

Table 89: Yuyue Medical Basic Information And Sales Area

Table 90: Yuyue Medical. Products Portfolio

Table 91: Global Market Value (USD Million) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Value (USD Million) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Market Volume (K) (2025-2032) By Application

Table 96: Global Market Share (%) By Application (2032)

Table 97: Global Market Volume (K) (2025-2032) By Types

Table 98: Global Market Share (%) By Types (2032)

Table 99: Global Blood Based Glucose Monitoring Market Value (USD Million) By Region

Table 100: Global Blood Based Glucose Monitoring Market Share (%) By Region (2025-2032)

Table 101: North America Market Value (USD Million) (2025-2032) By Country

Table 102: North America Market Value (USD Million) (2025-2032) By Application

Table 103: North America Market Value (USD Million) (2025-2032) By Types

Table 104: Europe Market Value (USD Million) (2025-2032) By Country

Table 105: Europe Market Value (USD Million) (2025-2032) By Application

Table 106: Europe Market Value (USD Million) (2025-2032) By Types

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 108: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 109: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 110: South America Market Value (USD Million) (2025-2032) By Country

Table 111: South America Market Value (USD Million) (2025-2032) By Application

Table 112: South America Market Value (USD Million) (2025-2032) By Types

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 114: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 115: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 116: Global Blood Based Glucose Monitoring Market Volume (K) By Region

Table 117: Global Blood Based Glucose Monitoring Market Share (%) By Region (2025-2032)

Table 118: North America Market Volume (K) (2025-2032) By Country

Table 119: North America Market Volume (K) (2025-2032) By Application

Table 120: North America Market Volume (K) (2025-2032) By Types

Table 121: Europe Market Volume (K) (2025-2032) By Country

Table 122: Europe Market Volume (K) (2025-2032) By Application

Table 123: Europe Market Volume (K) (2025-2032) By Types

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 125: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 126: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 127: South America Market Volume (K) (2025-2032) By Country

Table 128: South America Market Volume (K) (2025-2032) By Application

Table 129: South America Market Volume (K) (2025-2032) By Types

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 131: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 132: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 133: Research Programs/Design For This Report

Table 134: Key Data Information From Secondary Sources

Table 135: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Blood Based Glucose Monitoring Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 billion
Revenue forecast in 2033	3.66 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; LifeScan; Abbott; Ascensia; ARKRAY; I-SENS; Omron; B. Braun; 77 Elektronika; AgaMatrix; ALL Medicus; Terumo; Yicheng; Acon; Medtrum Technologies; MicroTech Medical, Inc; Sinocare; Hybio Pharmaceutical; Lepu Medical; Yuyue Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Blood Based Glucose Monitoring Segmentation Breakdown7 items

Application

Hospitals

Clinics

Others

Types

Wearable Blood Glucose Monitoring Systems

Table Top Blood Glucose Monitoring Systems

Regional Insights

Loading chart…

Key Regional Drivers5 items

North America: High adoption of CGM devices, FDA approvals for innovative glucose monitoring technologies, and a strong presence of market leaders like Dexcom and Abbott.

Europe: Stringent regulatory standards (CE marking), aging demographics, and public-private investments in diabetes management infrastructure.

Asia Pacific: Rapid urbanization, rising disposable incomes, and government-funded healthcare programs in China and India.

Latin America: Growing partnerships with global manufacturers and increasing penetration of affordable biosensor technologies.

Middle East & Africa: Expansion of telemedicine platforms and rising awareness of diabetes management in Gulf Cooperation Council (GCC) nations.

Competitive Landscape

Roche: Innovation pipeline for next-gen biosensor integration

LifeScan: OEM tie-ups for cost-competitive test strip production

Abbott: Regional expansion in Asia-Pacific via local manufacturing hubs

Ascensia: Premium pricing with hospital-grade device specialization

ARKRAY: Vertical integration to control supply chain risks

I-SENS: Digital health partnerships for connected glucose monitoring

Key Blood Based Glucose Monitoring Companies20 items

Roche

LifeScan

Abbott

Ascensia

ARKRAY

I-SENS

Omron

B. Braun

77 Elektronika

AgaMatrix

ALL Medicus

Terumo

Yicheng

Acon

Medtrum Technologies

MicroTech Medical, Inc

Sinocare

Hybio Pharmaceutical

Lepu Medical

Yuyue Medical

Market Ecosystem

Raw material/component suppliers — provide sensors, reagents, and plastics for device manufacturing

OEMs/Manufacturers — design and produce blood glucose meters and test strips

Technology providers — develop sensor technology and data analytics platforms

System integrators — facilitate integration with electronic health records (EHRs) and healthcare IT systems

Distributors/Channel partners — supply products to pharmacies, hospitals, and retail outlets

Service providers — offer calibration services, repairs, and user training for devices

End users — include patients with diabetes, healthcare professionals, and clinical facilities

Recent Industry Insights

Analyst Overview

Key Risk Factors3 items

Stringent regulatory requirements delaying product approvals

Price sensitivity in emerging markets

Technological obsolescence due to rapid innovation cycles

Table of Contents